These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 23827477)
21. Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota? Li DY; Yang M; Edwards S; Ye SQ JPEN J Parenter Enteral Nutr; 2013 Nov; 37(6):787-93. PubMed ID: 23538296 [TBL] [Abstract][Full Text] [Related]
22. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Moore JB Proc Nutr Soc; 2010 May; 69(2):211-20. PubMed ID: 20158939 [TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model. Aparicio-Vergara M; Hommelberg PP; Schreurs M; Gruben N; Stienstra R; Shiri-Sverdlov R; Kloosterhuis NJ; de Bruin A; van de Sluis B; Koonen DP; Hofker MH Hepatology; 2013 Feb; 57(2):566-76. PubMed ID: 22941955 [TBL] [Abstract][Full Text] [Related]
25. Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Yilmaz Y Aliment Pharmacol Ther; 2012 Nov; 36(9):815-23. PubMed ID: 22966992 [TBL] [Abstract][Full Text] [Related]
26. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Verna EC; Berk PD Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297 [TBL] [Abstract][Full Text] [Related]
27. Liver fibrogenesis and metabolic factors. Anty R; Lemoine M Clin Res Hepatol Gastroenterol; 2011 Jun; 35 Suppl 1():S10-20. PubMed ID: 21742296 [TBL] [Abstract][Full Text] [Related]
28. Non-alcoholic fatty liver disease. Leclercq I Bull Mem Acad R Med Belg; 2010; 165(3-4):147-55; discussion 155-8. PubMed ID: 21166266 [TBL] [Abstract][Full Text] [Related]
33. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Le Roy T; Llopis M; Lepage P; Bruneau A; Rabot S; Bevilacqua C; Martin P; Philippe C; Walker F; Bado A; Perlemuter G; Cassard-Doulcier AM; Gérard P Gut; 2013 Dec; 62(12):1787-94. PubMed ID: 23197411 [TBL] [Abstract][Full Text] [Related]
34. Non-alcoholic fatty liver disease pathogenesis: the present and the future. Petta S; Muratore C; Craxì A Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251 [TBL] [Abstract][Full Text] [Related]
35. Food-derived peroxidized fatty acids may trigger hepatic inflammation: a novel hypothesis to explain steatohepatitis. Böhm T; Berger H; Nejabat M; Riegler T; Kellner F; Kuttke M; Sagmeister S; Bazanella M; Stolze K; Daryabeigi A; Bintner N; Murkovic M; Wagner KH; Schulte-Hermann R; Rohr-Udilova N; Huber W; Grasl-Kraupp B J Hepatol; 2013 Sep; 59(3):563-70. PubMed ID: 23665282 [TBL] [Abstract][Full Text] [Related]
36. A novel non-alcoholic steatohepatitis animal model featured with insulin resistance, hepatic inflammation and fibrosis. Zhao J; Zhou G; Li M; Li W; Lü J; Xiong L; Liang L; Zhao Y; Xu D; Yu J Scand J Gastroenterol; 2010 Nov; 45(11):1360-71. PubMed ID: 20560816 [TBL] [Abstract][Full Text] [Related]